Pociredir clinical trials
Also written FTX-6058.
- studies test it
- 4
- open now
- 0
- in phase 3
- 0
- first study started
- 2020
How each study uses pociredir is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
Studies by the year they started
4 studies that test it; most in 2020 (1)
| Year | Studies |
|---|---|
| 2020 | 1 |
| 2021 | 1 |
| 2025 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 4 · Other 0
Fulcrum Therapeutics (4)
Studies
Open first, then newest update. How each study uses pociredir is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 4
- Open-Label Extension Study to Pioneer Study 6058-SCD-101TerminatedPhase 2Fulcrum TherapeuticsNCT07401823Written as Pociredir
- Single-dose Pharmacokinetics of Pociredir in Participants With Sickle Cell DiseaseTerminatedPhase 1Fulcrum TherapeuticsNCT07431398Written as Pociredir
- Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PociredirCompletedPhase 1Fulcrum TherapeuticsNCT05169580Written as Pociredir oral capsule(s)
- Safety, Tolerability and Pharmacokinetics of FTX-6058CompletedPhase 1Fulcrum TherapeuticsNCT04586985Written as FTX-6058 - Two Dosing Periods
Codes
What other systems call pociredir · ClinicalTrials.gg INT016094
- UNII (FDA) BC2SSV7WMTPOCIREDIROne source FDA
- NCI Thesaurus C190423PociredirOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | BC2SSV7WMT | POCIREDIR | One source FDA |
| NCI Thesaurus | C190423 | Pociredir | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.